Portfolio Manager Factsheet

August 2016

Wright Medical Group announced better than expected second quarter results and raised full year guidance. Ono Pharmaceutical and Bristol-Myers Squibb retraced on news that Opdivo, a successful cancer drug, had failed a late stage trial for treating lung cancer.  

Read more »

Register for email alerts

Worldwide Healthcare Trust PLC conducts its affairs so that its shares can be recommended by independent financial advisers (IFAs) to retail private investors. The shares are excluded from the Financial Conduct Authority's (FCA's) restrictions which apply to non-mainstream investment products because they are shares in a UK-listed investment trust.